GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sin3a
|
ENSRNOG00000032254 | SIN3 transcription regulator family member A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sin3a | rn6_v1_chr8_+_61762768_61762773 | 0.35 | 1.4e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_113319456 | 23.09 |
ENSRNOT00000051354
|
Ckmt1
|
creatine kinase, mitochondrial 1 |
chr20_-_1984737 | 18.77 |
ENSRNOT00000040232
ENSRNOT00000051634 ENSRNOT00000079445 |
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr15_+_15275541 | 17.56 |
ENSRNOT00000012153
|
Cadps
|
calcium dependent secretion activator |
chr3_-_160301552 | 15.11 |
ENSRNOT00000014498
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr8_+_111600532 | 13.79 |
ENSRNOT00000081952
|
Rab6b
|
RAB6B, member RAS oncogene family |
chr14_-_85191557 | 13.62 |
ENSRNOT00000011604
|
Nefh
|
neurofilament heavy |
chr3_+_160391106 | 13.41 |
ENSRNOT00000016981
|
Ywhab
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
chr1_-_199270627 | 12.66 |
ENSRNOT00000026063
|
Stx1b
|
syntaxin 1B |
chr13_+_52976507 | 12.45 |
ENSRNOT00000090599
ENSRNOT00000011324 |
Kif21b
|
kinesin family member 21B |
chr9_+_73529612 | 12.34 |
ENSRNOT00000032430
|
Unc80
|
unc-80 homolog, NALCN activator |
chr7_-_107009330 | 12.32 |
ENSRNOT00000074573
|
Kcnq3
|
potassium voltage-gated channel subfamily Q member 3 |
chr3_+_113318563 | 12.15 |
ENSRNOT00000089230
|
Ckmt1
|
creatine kinase, mitochondrial 1 |
chr4_-_157294047 | 12.07 |
ENSRNOT00000005601
|
Eno2
|
enolase 2 |
chr10_-_74679858 | 11.89 |
ENSRNOT00000003859
|
Ppm1e
|
protein phosphatase, Mg2+/Mn2+ dependent, 1E |
chr9_+_20251521 | 11.76 |
ENSRNOT00000005535
|
LOC100911625
|
gamma-enolase-like |
chrX_+_156963870 | 11.60 |
ENSRNOT00000077109
|
Pdzd4
|
PDZ domain containing 4 |
chr7_+_94130852 | 11.48 |
ENSRNOT00000011485
|
Mal2
|
mal, T-cell differentiation protein 2 |
chrX_+_105239620 | 11.36 |
ENSRNOT00000085693
|
Drp2
|
dystrophin related protein 2 |
chr3_+_161433410 | 11.35 |
ENSRNOT00000024657
|
Slc12a5
|
solute carrier family 12 member 5 |
chrX_-_15707436 | 10.96 |
ENSRNOT00000085907
|
Syp
|
synaptophysin |
chr7_-_50638798 | 10.85 |
ENSRNOT00000048880
|
Syt1
|
synaptotagmin 1 |
chr6_+_64297888 | 10.83 |
ENSRNOT00000050222
ENSRNOT00000083088 ENSRNOT00000093147 |
Nrcam
|
neuronal cell adhesion molecule |
chr1_-_85300825 | 10.74 |
ENSRNOT00000057073
ENSRNOT00000026900 |
Lrfn1
|
leucine rich repeat and fibronectin type III domain containing 1 |
chr7_+_140315368 | 10.61 |
ENSRNOT00000081206
|
Cacnb3
|
calcium voltage-gated channel auxiliary subunit beta 3 |
chr4_+_30807879 | 10.53 |
ENSRNOT00000013184
|
Dync1i1
|
dynein cytoplasmic 1 intermediate chain 1 |
chr13_-_88943592 | 10.51 |
ENSRNOT00000032218
|
LOC100361087
|
hypothetical LOC100361087 |
chr18_+_39172028 | 10.49 |
ENSRNOT00000086651
|
Kcnn2
|
potassium calcium-activated channel subfamily N member 2 |
chr1_+_162768156 | 10.40 |
ENSRNOT00000049321
|
Pak1
|
p21 (RAC1) activated kinase 1 |
chr7_+_78558701 | 10.24 |
ENSRNOT00000006393
|
Rims2
|
regulating synaptic membrane exocytosis 2 |
chrX_+_105239840 | 10.05 |
ENSRNOT00000039864
|
Drp2
|
dystrophin related protein 2 |
chr4_-_146016325 | 10.04 |
ENSRNOT00000067931
|
Atp2b2
|
ATPase plasma membrane Ca2+ transporting 2 |
chr2_-_186245771 | 10.02 |
ENSRNOT00000066004
ENSRNOT00000079954 |
Dclk2
|
doublecortin-like kinase 2 |
chr3_-_66417741 | 10.00 |
ENSRNOT00000007662
|
Neurod1
|
neuronal differentiation 1 |
chr15_+_108908607 | 9.83 |
ENSRNOT00000089455
|
Zic2
|
Zic family member 2 |
chr2_-_186245163 | 9.80 |
ENSRNOT00000089339
|
Dclk2
|
doublecortin-like kinase 2 |
chr1_+_219077771 | 9.76 |
ENSRNOT00000022824
|
Chka
|
choline kinase alpha |
chr4_+_175729726 | 9.74 |
ENSRNOT00000013230
|
Slco1c1
|
solute carrier organic anion transporter family, member 1c1 |
chr17_+_41798783 | 9.59 |
ENSRNOT00000023519
|
Nrsn1
|
neurensin 1 |
chr8_-_98738446 | 9.57 |
ENSRNOT00000019860
|
Zic1
|
Zic family member 1 |
chr6_+_27768943 | 9.48 |
ENSRNOT00000015820
|
Kif3c
|
kinesin family member 3C |
chr1_-_54748763 | 9.45 |
ENSRNOT00000074549
|
LOC100911027
|
protein MAL2-like |
chr7_+_54980120 | 9.26 |
ENSRNOT00000005690
ENSRNOT00000005773 |
Kcnc2
|
potassium voltage-gated channel subfamily C member 2 |
chr14_+_77380262 | 9.23 |
ENSRNOT00000008030
|
Nsg1
|
neuron specific gene family member 1 |
chr12_-_44911147 | 9.11 |
ENSRNOT00000071074
ENSRNOT00000046190 |
Ksr2
|
kinase suppressor of ras 2 |
chr10_-_108196217 | 8.96 |
ENSRNOT00000075440
|
Cbx4
|
chromobox 4 |
chrX_-_157312028 | 8.90 |
ENSRNOT00000077979
|
Atp2b3
|
ATPase plasma membrane Ca2+ transporting 3 |
chr17_-_10766253 | 8.86 |
ENSRNOT00000000117
|
Cplx2
|
complexin 2 |
chr7_+_145117951 | 8.65 |
ENSRNOT00000055272
|
Pde1b
|
phosphodiesterase 1B |
chrX_+_74200972 | 8.61 |
ENSRNOT00000076956
|
Chic1
|
cysteine-rich hydrophobic domain 1 |
chr18_+_39335377 | 8.53 |
ENSRNOT00000083642
ENSRNOT00000067262 ENSRNOT00000022530 |
Kcnn2
|
potassium calcium-activated channel subfamily N member 2 |
chr15_-_87540378 | 8.53 |
ENSRNOT00000093260
|
Mycbp2
|
MYC binding protein 2, E3 ubiquitin protein ligase |
chr1_-_198454914 | 8.52 |
ENSRNOT00000049044
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr5_+_127404450 | 8.45 |
ENSRNOT00000017575
|
Lrp8
|
LDL receptor related protein 8 |
chr3_-_176816114 | 8.40 |
ENSRNOT00000079262
ENSRNOT00000018697 |
Stmn3
|
stathmin 3 |
chr2_-_186245342 | 8.35 |
ENSRNOT00000057062
ENSRNOT00000022292 |
Dclk2
|
doublecortin-like kinase 2 |
chr19_+_20607507 | 8.34 |
ENSRNOT00000000011
|
Cbln1
|
cerebellin 1 precursor |
chr7_-_140437467 | 8.27 |
ENSRNOT00000087181
|
Fkbp11
|
FK506 binding protein 11 |
chr4_+_21317695 | 8.26 |
ENSRNOT00000007572
|
Grm3
|
glutamate metabotropic receptor 3 |
chr8_-_44327551 | 8.15 |
ENSRNOT00000083939
|
Gramd1b
|
GRAM domain containing 1B |
chr7_+_70364813 | 8.08 |
ENSRNOT00000084012
ENSRNOT00000031230 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr6_-_99870024 | 8.07 |
ENSRNOT00000010043
|
Rab15
|
RAB15, member RAS oncogene family |
chr4_-_117268178 | 8.05 |
ENSRNOT00000043201
ENSRNOT00000084049 |
Fbxo41
|
F-box protein 41 |
chrX_-_22413714 | 8.04 |
ENSRNOT00000084129
ENSRNOT00000085905 |
Tspyl2
|
TSPY-like 2 |
chr19_+_31524671 | 8.02 |
ENSRNOT00000024616
|
Hhip
|
Hedgehog-interacting protein |
chr11_+_50781127 | 7.93 |
ENSRNOT00000002738
|
Alcam
|
activated leukocyte cell adhesion molecule |
chr3_-_111560556 | 7.90 |
ENSRNOT00000030532
|
Ltk
|
leukocyte receptor tyrosine kinase |
chr13_+_70379346 | 7.90 |
ENSRNOT00000038183
|
Nmnat2
|
nicotinamide nucleotide adenylyltransferase 2 |
chr10_+_90348299 | 7.90 |
ENSRNOT00000089616
|
Rundc3a
|
RUN domain containing 3A |
chr5_-_151709877 | 7.88 |
ENSRNOT00000080602
|
Trnp1
|
TMF1-regulated nuclear protein 1 |
chr11_+_58624198 | 7.86 |
ENSRNOT00000002091
|
Gap43
|
growth associated protein 43 |
chr1_+_219078029 | 7.85 |
ENSRNOT00000023020
|
Chka
|
choline kinase alpha |
chr12_+_14021727 | 7.79 |
ENSRNOT00000060608
|
Mmd2
|
monocyte to macrophage differentiation-associated 2 |
chr9_+_17841410 | 7.73 |
ENSRNOT00000031706
|
Tmem151b
|
transmembrane protein 151B |
chrX_+_74205842 | 7.73 |
ENSRNOT00000077003
|
Chic1
|
cysteine-rich hydrophobic domain 1 |
chr3_-_79390956 | 7.68 |
ENSRNOT00000077943
|
Ptprj
|
protein tyrosine phosphatase, receptor type, J |
chrX_+_108287068 | 7.54 |
ENSRNOT00000093348
|
Il1rapl2
|
interleukin 1 receptor accessory protein-like 2 |
chrX_-_74968405 | 7.50 |
ENSRNOT00000035653
|
RGD1561931
|
similar to KIAA2022 protein |
chr7_-_119352605 | 7.48 |
ENSRNOT00000008414
|
Cacng2
|
calcium voltage-gated channel auxiliary subunit gamma 2 |
chr3_-_107760550 | 7.44 |
ENSRNOT00000077091
ENSRNOT00000051638 |
Meis2
|
Meis homeobox 2 |
chr3_+_55094637 | 7.37 |
ENSRNOT00000058763
|
Cers6
|
ceramide synthase 6 |
chr19_-_26053762 | 7.37 |
ENSRNOT00000004646
|
MAST1
|
microtubule associated serine/threonine kinase 1 |
chr12_+_49626871 | 7.35 |
ENSRNOT00000082593
|
Grk3
|
G protein-coupled receptor kinase 3 |
chr6_+_144384773 | 7.24 |
ENSRNOT00000006942
|
Ptprn2
|
protein tyrosine phosphatase, receptor type N2 |
chr5_+_139790395 | 7.21 |
ENSRNOT00000015033
|
Rims3
|
regulating synaptic membrane exocytosis 3 |
chr16_-_39719187 | 7.15 |
ENSRNOT00000092971
|
Gpm6a
|
glycoprotein m6a |
chr3_-_2534375 | 7.11 |
ENSRNOT00000037725
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1 |
chr3_+_2462466 | 7.05 |
ENSRNOT00000014087
|
Rnf208
|
ring finger protein 208 |
chr1_-_31122093 | 7.00 |
ENSRNOT00000016712
|
NEWGENE_1307525
|
SOGA family member 3 |
chr3_-_2534663 | 6.99 |
ENSRNOT00000049297
ENSRNOT00000044246 |
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1 |
chr5_-_16140896 | 6.93 |
ENSRNOT00000029503
|
Xkr4
|
XK related 4 |
chr3_+_56861396 | 6.87 |
ENSRNOT00000000008
ENSRNOT00000084375 |
Gad1
|
glutamate decarboxylase 1 |
chr10_+_55675575 | 6.85 |
ENSRNOT00000057295
|
Vamp2
|
vesicle-associated membrane protein 2 |
chr17_-_48562838 | 6.84 |
ENSRNOT00000017102
ENSRNOT00000084702 |
Amph
|
amphiphysin |
chr9_+_73493027 | 6.84 |
ENSRNOT00000074427
ENSRNOT00000089478 |
Unc80
|
unc-80 homolog, NALCN activator |
chr5_-_21345805 | 6.83 |
ENSRNOT00000081296
ENSRNOT00000007802 |
Car8
|
carbonic anhydrase 8 |
chr4_+_157511642 | 6.79 |
ENSRNOT00000065846
|
Pianp
|
PILR alpha associated neural protein |
chr2_-_219262901 | 6.79 |
ENSRNOT00000037068
|
Gpr88
|
G-protein coupled receptor 88 |
chr10_+_13854339 | 6.77 |
ENSRNOT00000004486
ENSRNOT00000043951 |
Caskin1
|
CASK interacting protein 1 |
chr1_+_78820262 | 6.65 |
ENSRNOT00000022441
|
Gng8
|
G protein subunit gamma 8 |
chr3_-_44342355 | 6.64 |
ENSRNOT00000059280
|
Acvr1c
|
activin A receptor type 1C |
chr5_-_173233188 | 6.63 |
ENSRNOT00000055343
|
Tmem88b
|
transmembrane protein 88B |
chr8_+_22050222 | 6.63 |
ENSRNOT00000028096
|
Icam5
|
intercellular adhesion molecule 5 |
chr5_-_74029238 | 6.62 |
ENSRNOT00000031432
|
Frrs1l
|
ferric-chelate reductase 1-like |
chr20_+_5535432 | 6.59 |
ENSRNOT00000040859
|
Syngap1
|
synaptic Ras GTPase activating protein 1 |
chr4_+_146106386 | 6.55 |
ENSRNOT00000008342
|
Slc6a11
|
solute carrier family 6 member 11 |
chr12_+_25036605 | 6.52 |
ENSRNOT00000001996
ENSRNOT00000084427 |
Limk1
|
LIM domain kinase 1 |
chr8_-_23282989 | 6.51 |
ENSRNOT00000019204
|
Zfp717
|
zinc finger protein 717 |
chrX_+_144445795 | 6.49 |
ENSRNOT00000048467
|
RGD1561327
|
similar to melanoma antigen family A, 10 |
chr13_-_44345735 | 6.46 |
ENSRNOT00000005006
|
Tmem163
|
transmembrane protein 163 |
chr1_+_221801524 | 6.45 |
ENSRNOT00000031227
|
Nrxn2
|
neurexin 2 |
chr6_-_98157087 | 6.43 |
ENSRNOT00000013275
|
Kcnh5
|
potassium voltage-gated channel subfamily H member 5 |
chr20_+_9743269 | 6.42 |
ENSRNOT00000001533
ENSRNOT00000083505 |
Abcg1
|
ATP binding cassette subfamily G member 1 |
chr2_-_170460754 | 6.36 |
ENSRNOT00000013009
|
Slitrk3
|
SLIT and NTRK-like family, member 3 |
chr1_-_197821936 | 6.28 |
ENSRNOT00000055027
|
Cd19
|
CD19 molecule |
chr15_+_51756978 | 6.27 |
ENSRNOT00000024067
|
Egr3
|
early growth response 3 |
chr9_+_80118029 | 6.25 |
ENSRNOT00000023068
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr19_-_11669578 | 6.22 |
ENSRNOT00000026373
|
Gnao1
|
G protein subunit alpha o1 |
chr16_-_28716885 | 6.19 |
ENSRNOT00000059750
|
Spock3
|
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3 |
chr5_+_143500441 | 6.06 |
ENSRNOT00000045513
|
Grik3
|
glutamate ionotropic receptor kainate type subunit 3 |
chr7_+_12006710 | 6.06 |
ENSRNOT00000045421
|
Klf16
|
Kruppel-like factor 16 |
chr1_+_100593892 | 6.04 |
ENSRNOT00000027062
|
Kcnc3
|
potassium voltage-gated channel subfamily C member 3 |
chr12_+_46615649 | 6.03 |
ENSRNOT00000086531
ENSRNOT00000089494 |
Bicdl1
|
BICD family like cargo adaptor 1 |
chr7_-_57679795 | 6.01 |
ENSRNOT00000007461
|
Trhde
|
thyrotropin-releasing hormone degrading enzyme |
chr7_+_77763512 | 6.00 |
ENSRNOT00000006411
|
Baalc
|
brain and acute leukemia, cytoplasmic |
chr19_+_24329544 | 5.89 |
ENSRNOT00000080934
|
Tbc1d9
|
TBC1 domain family member 9 |
chr7_-_139063752 | 5.88 |
ENSRNOT00000072309
|
LOC102551901
|
protein lifeguard 2-like |
chr19_+_25526751 | 5.85 |
ENSRNOT00000083448
|
Cacna1a
|
calcium voltage-gated channel subunit alpha1 A |
chr11_+_31389514 | 5.82 |
ENSRNOT00000000325
|
Olig2
|
oligodendrocyte lineage transcription factor 2 |
chr20_+_29655226 | 5.81 |
ENSRNOT00000089059
|
Spock2
|
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2 |
chr10_+_48903540 | 5.80 |
ENSRNOT00000004248
|
Trpv2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr3_+_111597102 | 5.76 |
ENSRNOT00000081462
|
Tyro3
|
TYRO3 protein tyrosine kinase |
chr3_+_122114754 | 5.75 |
ENSRNOT00000006408
|
Sirpa
|
signal-regulatory protein alpha |
chr1_+_100593680 | 5.74 |
ENSRNOT00000078153
ENSRNOT00000027063 |
Kcnc3
|
potassium voltage-gated channel subfamily C member 3 |
chr1_-_52992213 | 5.72 |
ENSRNOT00000033528
|
Prr18
|
proline rich 18 |
chr20_+_19318250 | 5.72 |
ENSRNOT00000000299
|
Phyhipl
|
phytanoyl-CoA 2-hydroxylase interacting protein-like |
chr13_+_25656983 | 5.71 |
ENSRNOT00000020892
|
RGD1307235
|
similar to RIKEN cDNA 2310035C23 |
chr6_-_131926272 | 5.64 |
ENSRNOT00000084057
ENSRNOT00000088421 |
Bcl11b
|
B-cell CLL/lymphoma 11B |
chrX_+_127562660 | 5.64 |
ENSRNOT00000029031
ENSRNOT00000010367 |
Gria3
|
glutamate ionotropic receptor AMPA type subunit 3 |
chr13_+_77602249 | 5.63 |
ENSRNOT00000003407
ENSRNOT00000076589 |
Tnr
|
tenascin R |
chr5_-_165083487 | 5.57 |
ENSRNOT00000036647
|
Disp3
|
dispatched RND transporter family member 3 |
chr2_-_118745766 | 5.53 |
ENSRNOT00000013858
|
Zmat3
|
zinc finger, matrin type 3 |
chr5_-_86696388 | 5.53 |
ENSRNOT00000007812
|
Megf9
|
multiple EGF-like-domains 9 |
chr8_-_57255263 | 5.52 |
ENSRNOT00000028972
|
LOC100125362
|
hypothetical protein LOC100125362 |
chr10_+_90342051 | 5.51 |
ENSRNOT00000028487
|
Rundc3a
|
RUN domain containing 3A |
chr6_+_43001948 | 5.49 |
ENSRNOT00000007374
|
Hpcal1
|
hippocalcin-like 1 |
chr8_-_116893057 | 5.48 |
ENSRNOT00000082113
|
Bsn
|
bassoon (presynaptic cytomatrix protein) |
chr10_+_55940533 | 5.47 |
ENSRNOT00000012061
|
RGD1563441
|
similar to RIKEN cDNA A030009H04 |
chr13_+_47739526 | 5.46 |
ENSRNOT00000006246
|
Il10
|
interleukin 10 |
chr2_+_209766512 | 5.43 |
ENSRNOT00000092240
|
Kcna3
|
potassium voltage-gated channel subfamily A member 3 |
chr2_+_136993208 | 5.41 |
ENSRNOT00000040187
ENSRNOT00000066542 |
Pcdh10
|
protocadherin 10 |
chr2_-_77632628 | 5.40 |
ENSRNOT00000073915
|
Basp1
|
brain abundant, membrane attached signal protein 1 |
chr13_-_49169918 | 5.39 |
ENSRNOT00000000036
|
Tmcc2
|
transmembrane and coiled-coil domain family 2 |
chr3_+_151310598 | 5.38 |
ENSRNOT00000092194
|
Mmp24
|
matrix metallopeptidase 24 |
chr8_-_103190243 | 5.37 |
ENSRNOT00000075305
|
Chst2
|
carbohydrate sulfotransferase 2 |
chr6_+_3657325 | 5.34 |
ENSRNOT00000010927
|
Tmem178a
|
transmembrane protein 178A |
chr9_+_82120059 | 5.33 |
ENSRNOT00000057368
|
Cdk5r2
|
cyclin-dependent kinase 5 regulatory subunit 2 |
chr10_-_14056169 | 5.27 |
ENSRNOT00000017833
|
Syngr3
|
synaptogyrin 3 |
chr9_+_82647071 | 5.23 |
ENSRNOT00000027135
|
Asic4
|
acid sensing ion channel subunit family member 4 |
chr2_+_195719543 | 5.22 |
ENSRNOT00000028324
|
Celf3
|
CUGBP, Elav-like family member 3 |
chr5_-_82168347 | 5.21 |
ENSRNOT00000084959
ENSRNOT00000084147 |
Astn2
|
astrotactin 2 |
chr1_-_211923929 | 5.18 |
ENSRNOT00000054887
|
Nkx6-2
|
NK6 homeobox 2 |
chr13_-_41738622 | 5.17 |
ENSRNOT00000004520
ENSRNOT00000084552 |
Actr3
|
ARP3 actin related protein 3 homolog |
chr1_-_265420503 | 5.17 |
ENSRNOT00000072223
|
Fbxw4
|
F-box and WD repeat domain containing 4 |
chr4_+_142453013 | 5.16 |
ENSRNOT00000056573
|
AABR07061755.1
|
|
chr3_+_81498022 | 5.16 |
ENSRNOT00000010510
|
Chst1
|
carbohydrate sulfotransferase 1 |
chr10_-_13898855 | 5.15 |
ENSRNOT00000004249
|
Rab26
|
RAB26, member RAS oncogene family |
chr1_-_52544450 | 5.14 |
ENSRNOT00000043474
|
Pde10a
|
phosphodiesterase 10A |
chr1_-_216080287 | 5.11 |
ENSRNOT00000027682
|
Th
|
tyrosine hydroxylase |
chr11_-_11585765 | 5.11 |
ENSRNOT00000066439
|
Robo2
|
roundabout guidance receptor 2 |
chr1_+_84470829 | 5.10 |
ENSRNOT00000025472
|
Ttc9b
|
tetratricopeptide repeat domain 9B |
chr1_+_40529045 | 5.09 |
ENSRNOT00000026564
|
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chrX_+_69580015 | 5.05 |
ENSRNOT00000057920
|
Fam155b
|
family with sequence similarity 155, member B |
chr4_+_57050214 | 5.02 |
ENSRNOT00000025165
|
Ahcyl2
|
adenosylhomocysteinase-like 2 |
chr1_+_101682172 | 5.02 |
ENSRNOT00000028540
|
Car11
|
carbonic anhydrase 11 |
chr14_+_25589762 | 5.01 |
ENSRNOT00000043938
ENSRNOT00000067439 ENSRNOT00000002793 |
Epha5
|
EPH receptor A5 |
chr8_-_94564525 | 5.01 |
ENSRNOT00000084437
|
Snap91
|
synaptosomal-associated protein 91 |
chr11_+_31428358 | 5.00 |
ENSRNOT00000002827
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr3_+_2262253 | 4.98 |
ENSRNOT00000042100
ENSRNOT00000061303 ENSRNOT00000048137 ENSRNOT00000048353 ENSRNOT00000012129 |
Nsmf
|
NMDA receptor synaptonuclear signaling and neuronal migration factor |
chrX_+_1321315 | 4.95 |
ENSRNOT00000014250
|
Syn1
|
synapsin I |
chr3_+_154043873 | 4.94 |
ENSRNOT00000072502
ENSRNOT00000034166 |
Nnat
|
neuronatin |
chr6_+_133576568 | 4.92 |
ENSRNOT00000085933
|
Dlk1
|
delta like non-canonical Notch ligand 1 |
chr18_+_30172740 | 4.90 |
ENSRNOT00000027340
|
Pcdha4
|
protocadherin alpha 4 |
chr19_-_57192095 | 4.88 |
ENSRNOT00000058080
|
Pgbd5
|
piggyBac transposable element derived 5 |
chr8_-_61290240 | 4.87 |
ENSRNOT00000023084
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr10_-_64915148 | 4.87 |
ENSRNOT00000048543
|
Sez6
|
seizure related 6 homolog |
chr14_-_83062302 | 4.86 |
ENSRNOT00000086769
ENSRNOT00000085735 |
Ywhah
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
chr4_-_119327822 | 4.85 |
ENSRNOT00000012645
|
Arhgap25
|
Rho GTPase activating protein 25 |
chr7_-_59514939 | 4.84 |
ENSRNOT00000085579
|
Kcnmb4
|
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
chr1_-_170404056 | 4.83 |
ENSRNOT00000024402
|
Apbb1
|
amyloid beta precursor protein binding family B member 1 |
chr18_+_59748444 | 4.82 |
ENSRNOT00000024752
|
St8sia3
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
chr1_-_72727112 | 4.80 |
ENSRNOT00000031172
|
Brsk1
|
BR serine/threonine kinase 1 |
chr20_-_31598118 | 4.77 |
ENSRNOT00000046537
|
Col13a1
|
collagen type XIII alpha 1 chain |
chr1_+_89215266 | 4.76 |
ENSRNOT00000093612
ENSRNOT00000084799 |
Dmkn
|
dermokine |
chr1_+_20332371 | 4.75 |
ENSRNOT00000037259
|
Tmem200a
|
transmembrane protein 200A |
chr9_-_28972835 | 4.74 |
ENSRNOT00000086967
ENSRNOT00000079684 |
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr3_-_60795951 | 4.72 |
ENSRNOT00000002174
|
Atf2
|
activating transcription factor 2 |
chr1_-_42587666 | 4.72 |
ENSRNOT00000083225
ENSRNOT00000025355 |
Rgs17
|
regulator of G-protein signaling 17 |
chr1_-_64405149 | 4.72 |
ENSRNOT00000089944
|
Cacng7
|
calcium voltage-gated channel auxiliary subunit gamma 7 |
chr14_-_43143973 | 4.70 |
ENSRNOT00000003248
|
Uchl1
|
ubiquitin C-terminal hydrolase L1 |
chr3_+_159823878 | 4.69 |
ENSRNOT00000011748
|
Gdap1l1
|
ganglioside-induced differentiation-associated protein 1-like 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.6 | GO:1903165 | response to polycyclic arene(GO:1903165) |
4.9 | 19.4 | GO:0021586 | pons maturation(GO:0021586) |
4.5 | 13.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
4.2 | 12.7 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
3.7 | 11.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
3.4 | 20.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
3.0 | 8.9 | GO:0031632 | positive regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031632) |
2.8 | 8.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.8 | 8.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
2.7 | 21.3 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
2.6 | 7.9 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.6 | 10.4 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
2.6 | 15.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
2.5 | 12.7 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
2.5 | 9.8 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
2.4 | 7.3 | GO:0043324 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
2.3 | 20.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
2.3 | 20.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.2 | 6.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
2.2 | 6.5 | GO:0060082 | eye blink reflex(GO:0060082) |
2.1 | 27.1 | GO:1901660 | calcium ion export(GO:1901660) |
2.0 | 10.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.0 | 6.1 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
2.0 | 10.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.9 | 5.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.8 | 5.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.8 | 12.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.8 | 10.9 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
1.7 | 8.6 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.7 | 6.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.7 | 6.8 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.7 | 5.1 | GO:0015942 | formate metabolic process(GO:0015942) |
1.7 | 15.2 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
1.7 | 16.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.6 | 3.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.6 | 9.6 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
1.6 | 4.8 | GO:1990743 | protein sialylation(GO:1990743) |
1.6 | 9.6 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
1.6 | 4.7 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.6 | 4.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
1.6 | 28.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.5 | 4.6 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
1.5 | 9.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
1.5 | 6.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.5 | 12.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.5 | 4.4 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
1.5 | 16.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.5 | 4.4 | GO:0098759 | interleukin-1 biosynthetic process(GO:0042222) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) regulation of progesterone biosynthetic process(GO:2000182) |
1.5 | 4.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.5 | 4.4 | GO:0072054 | chemoattraction of axon(GO:0061642) renal outer medulla development(GO:0072054) |
1.4 | 4.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
1.4 | 4.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.4 | 27.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
1.4 | 8.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.3 | 8.1 | GO:0021759 | globus pallidus development(GO:0021759) |
1.3 | 1.3 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
1.3 | 3.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.3 | 7.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.3 | 9.2 | GO:0006868 | glutamine transport(GO:0006868) |
1.3 | 16.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.3 | 5.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.3 | 11.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.3 | 3.9 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
1.3 | 15.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.3 | 13.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.3 | 3.8 | GO:0002432 | granuloma formation(GO:0002432) |
1.3 | 3.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
1.3 | 6.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.3 | 1.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
1.2 | 4.9 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.2 | 10.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.2 | 4.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.2 | 4.6 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.2 | 5.8 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.1 | 3.4 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
1.1 | 6.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
1.1 | 2.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.1 | 5.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.0 | 47.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.0 | 5.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
1.0 | 3.0 | GO:0033364 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) mast cell secretory granule organization(GO:0033364) |
1.0 | 7.0 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) |
1.0 | 7.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 1.0 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
1.0 | 3.0 | GO:0019677 | NAD catabolic process(GO:0019677) |
1.0 | 3.0 | GO:0021997 | neural plate axis specification(GO:0021997) |
1.0 | 2.9 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
1.0 | 2.9 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) |
1.0 | 2.9 | GO:0021590 | hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) |
1.0 | 5.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 4.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.9 | 2.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.9 | 6.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.9 | 6.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.9 | 1.8 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.9 | 5.5 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.9 | 1.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.9 | 2.6 | GO:0046099 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) |
0.9 | 1.8 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.8 | 2.5 | GO:1904056 | regulation of cholangiocyte proliferation(GO:1904054) positive regulation of cholangiocyte proliferation(GO:1904056) |
0.8 | 1.7 | GO:0050893 | sensory processing(GO:0050893) |
0.8 | 3.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.8 | 2.4 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.8 | 2.4 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.8 | 3.2 | GO:2000318 | negative regulation of interleukin-1 beta secretion(GO:0050713) positive regulation of T-helper 17 type immune response(GO:2000318) |
0.8 | 3.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.8 | 4.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.8 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.8 | 0.8 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
0.8 | 1.5 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
0.8 | 3.8 | GO:2000327 | positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.7 | 2.2 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.7 | 3.0 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.7 | 2.9 | GO:0001552 | ovarian follicle atresia(GO:0001552) |
0.7 | 2.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 2.9 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.7 | 5.1 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.7 | 5.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.7 | 2.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.7 | 2.1 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.7 | 5.0 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.7 | 1.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.7 | 2.1 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.7 | 4.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.7 | 2.0 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.7 | 10.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.7 | 3.3 | GO:0061741 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
0.7 | 3.3 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.7 | 2.0 | GO:2000682 | positive regulation of rubidium ion transport(GO:2000682) positive regulation of rubidium ion transmembrane transporter activity(GO:2000688) |
0.7 | 7.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.7 | 9.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.6 | 4.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.6 | 1.3 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 1.9 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.6 | 0.6 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.6 | 3.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 1.9 | GO:0061743 | motor learning(GO:0061743) |
0.6 | 3.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.6 | 3.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.6 | 3.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.6 | 2.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.6 | 3.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.6 | 3.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.6 | 8.5 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.6 | 2.4 | GO:0043988 | histone H3-S10 phosphorylation(GO:0043987) histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 1.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 1.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 6.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.6 | 2.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.6 | 5.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.6 | 3.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.6 | 4.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 2.9 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 1.7 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
0.6 | 2.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.6 | 2.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 3.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 2.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.6 | 5.1 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.6 | 2.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.6 | 1.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.6 | 3.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.6 | 2.8 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.6 | 12.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.6 | 1.7 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.6 | 16.6 | GO:0019835 | cytolysis(GO:0019835) |
0.6 | 1.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.6 | 1.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 1.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.5 | 1.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.5 | 1.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.5 | 20.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.5 | 2.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.5 | 1.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.5 | 6.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 4.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 6.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 1.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 2.0 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.5 | 1.5 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.5 | 1.5 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.5 | 3.0 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 1.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.5 | 3.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.5 | 5.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.5 | 1.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.5 | 1.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 2.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.5 | 1.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.5 | 2.9 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.5 | 40.3 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.5 | 4.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 6.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 1.4 | GO:0035934 | corticosterone secretion(GO:0035934) |
0.5 | 1.4 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.5 | 0.5 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.5 | 3.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.5 | 3.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 8.9 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.5 | 1.9 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.5 | 2.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 1.4 | GO:1904444 | regulation of establishment of Sertoli cell barrier(GO:1904444) |
0.5 | 1.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.5 | 2.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 0.9 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) |
0.5 | 1.8 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 1.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 4.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 2.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 0.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 24.5 | GO:0008542 | visual learning(GO:0008542) |
0.4 | 3.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 3.0 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.4 | 3.0 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.4 | 2.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.4 | 7.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.4 | 3.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 3.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 33.7 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.4 | 2.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.4 | 6.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.4 | 4.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 1.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.4 | 6.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.4 | 3.3 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.4 | 1.7 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.4 | 1.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 5.8 | GO:0060068 | vagina development(GO:0060068) neuron cellular homeostasis(GO:0070050) |
0.4 | 2.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 4.9 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 4.0 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.4 | 1.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 0.8 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.4 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 2.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.4 | 3.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.4 | 1.2 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.4 | 1.2 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.4 | 4.6 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.4 | 1.9 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 1.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.4 | 1.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 1.8 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.4 | 13.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 1.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 1.8 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.4 | 5.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 1.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 10.5 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.3 | 0.3 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
0.3 | 7.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 5.6 | GO:0060992 | response to fungicide(GO:0060992) |
0.3 | 0.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 5.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.3 | 1.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 1.3 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) |
0.3 | 5.0 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 2.0 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.3 | 4.6 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 2.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 0.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 1.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 2.2 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
0.3 | 2.2 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.3 | 0.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 1.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.3 | 2.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 3.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 11.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 2.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 2.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.3 | 2.4 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 3.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.3 | 7.4 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.3 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 4.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 1.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 3.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.3 | 3.4 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.3 | 9.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 0.3 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 0.8 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 1.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 2.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 1.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 4.2 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.3 | 0.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 1.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 1.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 2.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 0.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.3 | 1.3 | GO:0009838 | abscission(GO:0009838) negative regulation of cytokinesis(GO:0032466) |
0.3 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 2.8 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 1.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 6.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 0.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 5.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 6.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.3 | 1.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 2.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 2.5 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.2 | 3.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 1.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 2.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 1.0 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 1.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 6.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 3.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.5 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.2 | 2.4 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 7.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 1.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.7 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 0.9 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 1.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 3.6 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 2.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.9 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.2 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 9.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 4.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 10.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 1.9 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 0.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 4.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 1.8 | GO:0071467 | cellular response to pH(GO:0071467) |
0.2 | 4.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.6 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.2 | 1.0 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.2 | 0.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 1.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 3.5 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 1.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 2.5 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 10.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 1.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 1.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 2.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.2 | 0.6 | GO:0060374 | mast cell differentiation(GO:0060374) regulation of mast cell differentiation(GO:0060375) |
0.2 | 7.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.7 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.5 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.2 | 1.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.2 | 3.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 1.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 2.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 1.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 5.7 | GO:0097502 | mannosylation(GO:0097502) |
0.2 | 1.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 2.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.2 | 0.7 | GO:0001554 | luteolysis(GO:0001554) |
0.2 | 3.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 3.7 | GO:0009268 | response to pH(GO:0009268) |
0.2 | 2.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 0.8 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 1.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 1.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 1.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 5.8 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.2 | 2.2 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 1.9 | GO:0001964 | startle response(GO:0001964) |
0.2 | 1.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 1.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 3.2 | GO:0090659 | walking behavior(GO:0090659) |
0.2 | 2.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 5.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 2.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 1.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 2.0 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 3.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 1.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 2.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 4.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 2.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 1.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 1.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.4 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 4.5 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 7.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.8 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 0.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 3.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 10.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 1.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.6 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 4.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 2.5 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.9 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.4 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 2.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 4.3 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.6 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 2.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 1.1 | GO:1990001 | positive regulation of protein polyubiquitination(GO:1902916) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 3.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 1.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 4.5 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 1.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.0 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.1 | 0.5 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 2.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 5.0 | GO:0006497 | protein lipidation(GO:0006497) |
0.1 | 1.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 1.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 1.7 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.1 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 1.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.5 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 1.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 2.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 1.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 1.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 2.0 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 1.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 2.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 1.9 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.6 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 1.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 2.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.2 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 2.8 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.4 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.1 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.0 | 1.0 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.8 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.9 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.4 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 2.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 1.0 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.7 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.3 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.5 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0046601 | positive regulation of centriole replication(GO:0046601) regulation of mitotic cytokinesis(GO:1902412) |
0.0 | 1.2 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 1.8 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.1 | GO:0000056 | ribosomal large subunit export from nucleus(GO:0000055) ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 1.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 18.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
5.3 | 16.0 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
4.1 | 24.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
4.0 | 16.0 | GO:0044307 | dendritic branch(GO:0044307) |
2.7 | 19.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.6 | 15.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.6 | 10.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
2.2 | 6.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
2.0 | 3.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.9 | 5.8 | GO:0060187 | cell pole(GO:0060187) |
1.9 | 13.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.9 | 5.6 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
1.9 | 29.6 | GO:0031045 | dense core granule(GO:0031045) |
1.8 | 9.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
1.8 | 5.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.7 | 22.7 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
1.7 | 13.7 | GO:0032584 | growth cone membrane(GO:0032584) |
1.5 | 8.9 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
1.4 | 4.2 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
1.4 | 16.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.4 | 13.6 | GO:0005883 | neurofilament(GO:0005883) |
1.3 | 60.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.2 | 33.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 26.3 | GO:0043194 | axon initial segment(GO:0043194) |
1.0 | 4.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 4.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.8 | 4.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 20.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.8 | 3.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 6.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.7 | 10.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 2.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.7 | 6.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.7 | 11.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.7 | 17.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.7 | 4.1 | GO:0008091 | spectrin(GO:0008091) |
0.7 | 27.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.7 | 3.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.6 | 18.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 1.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 3.0 | GO:0089701 | U2AF(GO:0089701) |
0.6 | 8.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 4.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 6.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 9.9 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 16.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.5 | 5.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 1.5 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
0.5 | 1.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 90.7 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 3.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 3.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 3.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 3.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 1.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 4.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 3.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 8.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 8.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.5 | 3.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.5 | 3.2 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.4 | 3.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 2.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.4 | 25.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 8.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 3.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 2.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 2.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 7.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 3.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 5.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 4.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 2.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 3.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.9 | GO:1990696 | stereocilia ankle link complex(GO:0002142) USH2 complex(GO:1990696) |
0.3 | 3.2 | GO:0097433 | dense body(GO:0097433) |
0.3 | 2.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 1.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 1.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 37.2 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 20.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 2.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 2.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 5.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 10.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 1.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 1.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 8.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 2.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 6.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 7.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 1.0 | GO:0097196 | Shu complex(GO:0097196) |
0.2 | 5.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 4.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 3.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 2.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 1.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 4.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 4.2 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 7.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.4 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 1.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 1.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 2.5 | GO:0030914 | STAGA complex(GO:0030914) transcription factor TFTC complex(GO:0033276) |
0.2 | 4.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.2 | 0.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 3.1 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.2 | 2.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 1.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 1.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 28.7 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 1.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 20.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 2.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 2.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.2 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 1.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 6.4 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 1.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 4.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.9 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 12.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 2.1 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 6.6 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.0 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 3.4 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 3.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 3.5 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 9.0 | GO:0005819 | spindle(GO:0005819) |
0.1 | 6.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 3.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 4.8 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 1.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 2.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 6.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 2.1 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 6.0 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 6.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.7 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 2.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.1 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 2.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 2.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.0 | 2.9 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 1.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 1.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 1.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 3.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 4.4 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 76.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.8 | GO:0005814 | centriole(GO:0005814) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 33.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
4.3 | 17.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
4.1 | 24.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
3.8 | 19.0 | GO:0004103 | choline kinase activity(GO:0004103) |
3.4 | 10.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
3.0 | 11.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.8 | 14.1 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
2.7 | 19.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.6 | 7.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.6 | 7.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
2.3 | 16.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.2 | 6.6 | GO:0038100 | nodal binding(GO:0038100) |
2.2 | 13.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.2 | 10.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
2.2 | 8.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.1 | 6.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
2.1 | 14.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.0 | 7.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.0 | 7.8 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
1.9 | 13.4 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.9 | 5.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.8 | 5.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.8 | 10.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.7 | 20.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.7 | 6.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.7 | 6.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.7 | 13.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.6 | 6.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.6 | 13.0 | GO:0034452 | dynactin binding(GO:0034452) |
1.6 | 4.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.5 | 4.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.5 | 9.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.5 | 28.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.5 | 6.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
1.5 | 4.4 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.4 | 4.3 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
1.4 | 5.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.3 | 29.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.3 | 9.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.3 | 4.0 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
1.3 | 7.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.3 | 13.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.3 | 3.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.3 | 9.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.3 | 5.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.3 | 5.1 | GO:0019002 | GMP binding(GO:0019002) |
1.3 | 3.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.3 | 5.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.2 | 8.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.2 | 10.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.2 | 9.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.2 | 8.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.1 | 13.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.1 | 4.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.1 | 5.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.1 | 32.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.1 | 6.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.1 | 4.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.0 | 3.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
1.0 | 4.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.0 | 5.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.0 | 3.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.0 | 7.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.9 | 3.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.9 | 1.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.9 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.9 | 8.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.8 | 2.5 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.8 | 8.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.8 | 4.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.8 | 15.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 1.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.8 | 2.3 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.7 | 3.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.7 | 5.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.7 | 9.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.7 | 2.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 8.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.7 | 3.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 6.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 4.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 2.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.7 | 0.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.7 | 5.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.7 | 4.7 | GO:0003896 | DNA primase activity(GO:0003896) |
0.7 | 3.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.7 | 2.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.6 | 14.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.6 | 2.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.6 | 5.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 3.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.6 | 1.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.6 | 14.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.6 | 9.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.6 | 7.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 7.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 2.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 11.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 3.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.6 | 4.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 4.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 5.0 | GO:0098748 | clathrin heavy chain binding(GO:0032050) clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 1.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.6 | 13.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 2.8 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.5 | 14.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 6.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 4.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.5 | 6.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 2.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 3.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 4.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 3.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 1.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.5 | 5.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 1.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.4 | 1.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 1.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.4 | 3.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 3.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.4 | 4.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.4 | 4.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 2.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 2.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 2.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 2.0 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 1.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.4 | 2.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 3.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.4 | 3.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 1.9 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.4 | 1.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 3.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 14.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 2.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 1.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.4 | 2.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 0.4 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.3 | 16.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.7 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.0 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.3 | 2.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 2.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 48.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 4.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 3.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 17.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 1.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.3 | 16.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 0.9 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 1.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 3.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 1.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 2.7 | GO:0098918 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of synapse(GO:0098918) structural constituent of postsynaptic density(GO:0098919) |
0.3 | 0.9 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.3 | 5.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 3.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 7.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 13.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 7.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 2.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 4.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 0.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.0 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
0.3 | 0.8 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.2 | 6.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 2.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.9 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.2 | 0.7 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 0.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 1.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 7.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 2.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 3.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 1.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 1.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 7.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 49.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 2.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.5 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.2 | 4.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.9 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 1.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 2.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 2.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 6.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 1.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 7.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 2.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 1.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 8.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 2.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 4.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 1.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 2.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.5 | GO:0052742 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 2.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.0 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 1.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 2.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0038132 | C-X3-C chemokine binding(GO:0019960) neuregulin binding(GO:0038132) |
0.1 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 6.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.7 | GO:0004321 | acyl-CoA ligase activity(GO:0003996) fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 1.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 2.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 4.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 1.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.0 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 1.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 1.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 2.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 8.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 1.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 1.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.0 | 1.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 1.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 1.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 1.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 1.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 1.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 1.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0005123 | death receptor binding(GO:0005123) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 33.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 2.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.6 | 6.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 25.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 7.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 14.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 4.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 3.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 8.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.4 | 2.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 8.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 7.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 3.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 13.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 8.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 17.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 8.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 2.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 5.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 5.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 11.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 2.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 2.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 4.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 8.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 4.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 7.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 6.0 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 6.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 3.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 2.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 3.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 4.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 3.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 9.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 3.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 3.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 3.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 3.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 4.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 31.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.4 | 19.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.3 | 29.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.2 | 21.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 19.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 24.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.9 | 20.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.9 | 47.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 22.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.9 | 13.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.9 | 14.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.9 | 25.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.8 | 12.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.8 | 7.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.8 | 10.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 4.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.6 | 4.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 5.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 8.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 2.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 6.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 7.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 11.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 5.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 1.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.4 | 13.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 4.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 16.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 7.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 6.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 5.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 4.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 2.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 5.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 11.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 4.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 3.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 3.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 4.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 3.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 6.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 5.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 9.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 1.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 8.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.3 | 3.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 4.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 4.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 3.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 18.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 5.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 1.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 3.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 1.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 5.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 4.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 12.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 8.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 3.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 7.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 2.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 4.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 5.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 3.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 3.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.9 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 7.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 4.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 5.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 3.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 4.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.9 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 3.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 1.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 2.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 3.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |